Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Halozyme Therapeutics, Inc. (NQ: HALO)
6.320 USD  -0.085 (-1.33%)
Official Closing Price  /  Updated: 4:00 PM EDT, Jun 19, 2013  /  Add to My Watchlist      
View: Quote Chart Options News SEC Filings
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open 6.410
Bid (Size) 6.320 (32700)
Ask (Size) 8.280 (500)
Prev. Close 6.405
Today's Range 6.310 - 6.550
52wk Range 3.860 - 9.920
Shares Outstanding 113,160,891
Dividend Yield N/A
Top News
More News
Short Interest In Halozyme Therapeutics Declines 12%
June 13, 2013
The most recent short interest data has been released by the NASDAQ for the 05/31/2013 settlement date, which shows a 1,217,926 share decrease in total short interest for Halozyme Therapeutics Inc... Read More
category Stocks
from Market News Video
Halozyme Therapeutics Inc Breaks Below 200-Day Moving Average - Notable for HALO
June 05, 2013
In trading on Wednesday, shares of Halozyme Therapeutics Inc (HALO) crossed below their 200 day moving average of $6.23, changing hands as low as $6.21 per share. Halozyme Therapeutics Inc shares are... Read More
category Stocks
from Market News Video

More News
Read More
Commit To Purchase Halozyme Therapeutics At $5, Earn 33.2% Annualized
June 03, 2013
category Dividends
from Dividend Channel
Halozyme's Phase 1b Clinical Trial Of PEGPH20 With Gemcitabine Indicates Positive Activity Against Pancreatic Cancer
June 03, 2013
from PR Newswire
Pre-Market Analysis on GILD, NPSP, HALO, SNTS, and ITMN
May 30, 2013
from ACCESSWIRE
Free Research Reports on ALKS, HALO, RL and VOYA Issued by the Paragon Report
May 24, 2013
from Marketwired News Releases
Halozyme (HALO) Names David Ramsay as CFO
May 23, 2013
from StreetInsider.com News Articles
Halozyme Therapeutics Names David A. Ramsay Chief Financial Officer
May 23, 2013
from PR Newswire
Bio-Wire Equity Surveillance – Closing Bell 5/22/2013
May 22, 2013
category Bio/Wire
from Bio-Wire.Com
Baxter Receives Marketing Authorization for HyQvia in European Union
May 21, 2013
from Business Wire News Releases
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here